Cancer and Population Studies Group; Queensland Institute of Medical Research; Herston, QLD Australia.
Epigenetics. 2013 Jul;8(7):748-55. doi: 10.4161/epi.25178. Epub 2013 Jun 17.
Changes in the methylation levels of DNA from white blood cells (WBCs) are putatively associated with an elevated risk for several cancers. The aim of this study was to investigate the association between colorectal cancer (CRC) and the methylation status of three DNA repetitive elements in DNA from peripheral blood. WBC DNA from 539 CRC cases diagnosed before 60 years of age and 242 sex and age frequency-matched healthy controls from the Australasian Colorectal Cancer Family Registry were assessed for methylation across DNA repetitive elements Alu, LINE-1 and Sat2 using MethyLight. The percentage of methylated reference (PMR) of cases and controls was calculated for each marker. Odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using multivariable logistic regression adjusted for potential confounders. CRC cases demonstrated a significantly higher median PMR for LINE-1 (p < 0.001), Sat2 (p < 0.001) and Alu repeats (p = 0.02) when compared with controls. For each of the DNA repetitive elements, individuals with PMR values in the highest quartile were significantly more likely to have CRC compared with those in the lowest quartile (LINE-1 OR = 2.34, 95%CI = 1.48-3.70; p < 0.001, Alu OR = 1.83, 95%CI = 1.17-2.86; p = 0.01, Sat2 OR = 1.72, 95%CI = 1.10-2.71; p = 0.02). When comparing the OR for the PMR of each marker across subgroups of CRC, only the Alu marker showed a significant difference in the 5-fluoruracil treated and nodal involvement subgroups (both p = 0.002). This association between increasing methylation levels of three DNA repetitive elements in WBC DNA and early-onset CRC is novel and may represent a potential epigenetic biomarker for early CRC detection.
白细胞(WBC)中的 DNA 甲基化水平的变化据称与几种癌症的风险增加有关。本研究的目的是调查结直肠癌(CRC)与外周血中三个 DNA 重复元件的甲基化状态之间的关联。来自澳大利亚结直肠癌症家族登记处的 539 名年龄在 60 岁以下被诊断为 CRC 的病例和 242 名性别和年龄匹配的健康对照者的 WBC DNA ,使用 MethyLight 评估了 DNA 重复元件 Alu、LINE-1 和 Sat2 中的甲基化。为每个标记计算了病例和对照组的甲基化参考百分比(PMR)。使用多变量逻辑回归模型,根据潜在的混杂因素进行调整,估计了比值比(OR)和 95%置信区间(CI)。与对照组相比,CRC 病例的 LINE-1(p <0.001)、Sat2(p <0.001)和 Alu 重复序列的中位数 PMR 明显更高(p <0.001)。对于每个 DNA 重复元件,PMR 值处于最高四分位数的个体与处于最低四分位数的个体相比,CRC 的可能性明显更高(LINE-1 OR = 2.34,95%CI = 1.48-3.70;p <0.001,Alu OR = 1.83,95%CI = 1.17-2.86;p = 0.01,Sat2 OR = 1.72,95%CI = 1.10-2.71;p = 0.02)。当比较每个标记的 PMR 比值在 CRC 亚组中的 OR 时,只有 Alu 标记在 5-氟尿嘧啶治疗和淋巴结受累亚组中显示出显着差异(均 p = 0.002)。WBC DNA 中三个 DNA 重复元件的甲基化水平升高与早发性 CRC 之间的这种关联是新颖的,可能代表早期 CRC 检测的潜在表观遗传生物标志物。